Neuronetrix Solutions

Neuronetrix Solutions is a private U.S. neurodiagnostics and digital biomarker company that does business as COGNISION. The company develops and commercializes EEG- and event-related potential-based systems for objective assessment of brain function in clinical practice, cognitive research, and CNS drug development. Its core offering, the COGNISION System, is an FDA-cleared neurodiagnostic device that automates acquisition and analysis of qEEG and ERP data for use in neurological evaluation. The company also markets Cognision360, a unified platform for collecting, managing, and analyzing neurobiomarker and related digital data in CNS clinical trials. In addition, Neuronetrix has organized industry collaborations around electrophysiology biomarkers, including the ERP Biomarker Qualification Consortium for schizophrenia drug development.